GLP1 Europe › Independent testing
Independent peptide testing, explained
Short answer
Yes, private individuals can pay accredited-grade laboratories to analyse a peptide sample, and in the grey market this is the only testing that means anything, because a seller's certificate is just a document.
But understand what you are buying before you spend the money. A test tells you what was in the vial you sent, which is destroyed by testing. It cannot tell you what is in the vial you kept, whether the next batch matches, or whether the contents are sterile, unless you pay separately for that too.
What consumer testing actually is
A handful of commercial analytical laboratories accept samples from private individuals, no institution required. The dominant one in this niche is Janoshik Analytical, a registered Czech company operating from Prague that has become the de facto standard in peptide communities. A small number of others exist in Czechia, Poland and the United States. We name Janoshik because its legal existence as a company is independently verifiable in the Czech commercial register; that is a statement that it is real, not an endorsement of its results.
The tests on offer, and what each one answers:
| Test | The question it answers | What it cannot tell you |
|---|---|---|
| Mass spectrometry identity | Is this molecule what the label claims? | How much of it there is |
| HPLC purity and quantity | How much of the peptide content is the right peptide, and how many milligrams are present | Anything about sterility or bacterial residues |
| Sterility | Is anything alive growing in it? | Whether dead bacteria left endotoxin behind |
| Endotoxin | Are bacterial cell-wall fragments present, the ones that cause fever and inflammation when injected? | Identity or dose |
Prices move and published figures conflict, so treat this only as an order of magnitude: identity plus purity typically runs somewhere in the low hundreds of dollars per compound, and a fuller panel with sterility and endotoxin several hundred. Check current prices directly with whichever laboratory you would use. For contrast, the study that tested grey-market semaglutide found the products themselves often cost less than the testing would.
What testing has found when researchers did it
The only peer-reviewed test-purchase study of grey-market semaglutide, published in the Journal of Medical Internet Research in 2024, is worth restating whenever this subject comes up. Claimed purity was 99 percent. Measured purity was 7.7 to 14.4 percent. Every sample contained endotoxin. Actual semaglutide content ran 29 to 39 percent over the labelled amount, meaning a buyer dosing by the label was taking a third more than intended, of a heavily impure product.
Eli Lilly's testing of products sold as tirzepatide found bacteria, high impurity levels, the wrong molecule entirely, and in one case nothing but a sugar alcohol. Interpol's 2026 sweep found illicit GLP-1 products containing sibutramine, banned in the EU since 2010. No published laboratory analysis of grey-market retatrutide vials existed as of the date on this page, which given everything above is not reassuring, it is simply untested.
The honest limits
The tested vial is gone. Analysis destroys the sample. What you inject is always a different vial, trusted by analogy. That analogy is weakened by the same study above, which found labelled content off by a third even in delivered product, batch to batch consistency is exactly what the grey market does not offer.
There is no chain of custody. A test result, like a certificate, proves what was in the sample the lab received. A vendor publishing a test number cannot prove the vial you received came from the tested batch. When you send a sample yourself, you close that gap for that one vial only.
Identity is not safety. The right molecule at the right dose can still carry endotoxin, be non-sterile, or degrade in shipping. Those are separate tests, usually separately priced, and often skipped because they cost more than the product.
Testing changes nothing legally. A tested unauthorised medicine is still an unauthorised medicine. What that means in your country is its own question.
The system all of this is substituting for is worth naming. An authorised medicine is manufactured under inspected conditions, released batch by batch by a legally responsible person, tracked by the barcode system, and monitored after launch, with a company legally answerable when something is wrong. Private testing replicates one slice of one of those layers, for one vial, at your expense. It is better than nothing. It is not the same thing.
Common questions
- Is a vendor's published test report worth anything?
It is worth more than no report, and less than it appears. Report portals verify that the document is real, not that your vial matches it. The JMIR study's sellers claimed 99 percent purity too.
- Should I test a pharmacy medicine?
There is no need. Pharmacy medicines are batch-released and barcode-verified through the system described on the fake pens page. Private testing exists because grey-market products have none of that.
- Can a lab tell me if a product is safe to inject?
No laboratory will certify that, and be wary of any that implies it. Tests answer narrow chemical questions. "Safe to inject" is a medical judgment that also depends on you, and nobody testing a vial can make it.
Sources
- Ashraf AR, Mackey TK, Vida RG, et al. Journal of Medical Internet Research, 2024;26:e65440. DOI 10.2196/65440.
- Belcourt J, Ly P, White CM. Annals of Pharmacotherapy, 2025;59(5). DOI 10.1177/10600280241277551.
- Eli Lilly, open letter regarding certain practices, 20 June 2024.
- Interpol, Operation Pangea XVIII, March 2026.
- Czech commercial register entry for Janoshik s.r.o., Prague, IČO 17668727, confirming corporate existence.
- European Pharmacopoeia, general chapters on chromatography, sterility and bacterial endotoxin testing.
This page explains what analytical testing can and cannot establish. It is not medical advice, it does not endorse any laboratory's results, and it should not be read as a method for making unauthorised medicines safe. No test makes an unlicensed injectable equivalent to an authorised one.